Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹8,769 Cr
up ₹121 Cr vs Aug 2024
- Stocks held
- 33
- unchanged
- Top 10 weight
- 60.1%
- of the portfolio in its ten largest
- Cash & debt
- 3.7%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 19
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In September 2024 it disclosed 33 stocks worth ₹8,769 Cr, up ₹121 Cr from Aug 2024. Its largest positions were Sun Pharmaceutical Industries Limited (14.4%), Divi's Laboratories Limited (8.4%), Lupin Limited (8.0%); the ten largest together made up 60.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 79.0% of its equity. Cash and debt stood at 3.7%. Compared with Aug 2024 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
84%
Top-10 weight is higher than 84% of peers
Breadth
18%
Holds more stocks than 18% of peers
Cash
56%
Holds more cash than 56% of peers
Holdings in September 2024
Download CSVEvery line the fund disclosed, with the change against Aug 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 14.41%
- Δ weight
- up 0.60 pts
- Value
- ₹1,263 Cr
- Δ value
- up ₹68.9 Cr
- Status
- Added
- Weight
- 8.39%
- Δ weight
- up 0.43 pts
- Value
- ₹735 Cr
- Δ value
- up ₹47.2 Cr
- Status
- Added
- Weight
- 8.01%
- Δ weight
- down 0.29 pts
- Value
- ₹702 Cr
- Δ value
- down ₹15.7 Cr
- Status
- Trimmed
- Weight
- 5.85%
- Δ weight
- down 0.08 pts
- Value
- ₹513 Cr
- Δ value
- down ₹25 L
- Status
- Held
- Weight
- 5.39%
- Δ weight
- down 0.30 pts
- Value
- ₹473 Cr
- Δ value
- down ₹19.6 Cr
- Status
- Trimmed
- Weight
- 5.33%
- Δ weight
- up 0.13 pts
- Value
- ₹467 Cr
- Δ value
- up ₹17.6 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 3.74%
- Δ weight
- up 1.14 pts
- Value
- ₹328 Cr
- Δ value
- up ₹103 Cr
- Status
- Added
- Weight
- 3.50%
- Δ weight
- down 0.10 pts
- Value
- ₹307 Cr
- Δ value
- down ₹4 Cr
- Status
- Trimmed
- Weight
- 3.31%
- Δ weight
- up 0.12 pts
- Value
- ₹290 Cr
- Δ value
- up ₹14.2 Cr
- Status
- Added
- Weight
- 3.07%
- Δ weight
- down 0.12 pts
- Value
- ₹269 Cr
- Δ value
- down ₹6.4 Cr
- Status
- Trimmed
- Weight
- 2.87%
- Δ weight
- down 0.14 pts
- Value
- ₹252 Cr
- Δ value
- down ₹8.9 Cr
- Status
- Trimmed
- Weight
- 2.84%
- Δ weight
- down 0.25 pts
- Value
- ₹249 Cr
- Δ value
- down ₹18.5 Cr
- Status
- Trimmed
- Weight
- 2.73%
- Δ weight
- down 0.15 pts
- Value
- ₹240 Cr
- Δ value
- down ₹10.1 Cr
- Status
- Trimmed
- Weight
- 2.61%
- Δ weight
- down 0.03 pts
- Value
- ₹229 Cr
- Δ value
- up ₹45 L
- Status
- Held
- Weight
- 2.59%
- Δ weight
- down <0.01 pts
- Value
- ₹227 Cr
- Δ value
- up ₹3 Cr
- Status
- Added
- Weight
- 2.44%
- Δ weight
- down 0.50 pts
- Value
- ₹214 Cr
- Δ value
- down ₹40.1 Cr
- Status
- Trimmed
- Weight
- 2.35%
- Δ weight
- down 0.06 pts
- Value
- ₹206 Cr
- Δ value
- down ₹2.7 Cr
- Status
- Trimmed
- Weight
- 2.14%
- Δ weight
- down 0.06 pts
- Value
- ₹188 Cr
- Δ value
- down ₹2.7 Cr
- Status
- Trimmed
- Weight
- 2.08%
- Δ weight
- down 0.16 pts
- Value
- ₹182 Cr
- Δ value
- down ₹10.9 Cr
- Status
- Trimmed
- Weight
- 1.95%
- Δ weight
- down 0.08 pts
- Value
- ₹171 Cr
- Δ value
- down ₹4.5 Cr
- Status
- Trimmed
- Weight
- 1.91%
- Δ weight
- down 0.06 pts
- Value
- ₹168 Cr
- Δ value
- down ₹3.3 Cr
- Status
- Trimmed
- Weight
- 1.85%
- Δ weight
- up 0.04 pts
- Value
- ₹162 Cr
- Δ value
- up ₹5.5 Cr
- Status
- Added
- Weight
- 1.64%
- Δ weight
- down 0.12 pts
- Value
- ₹143 Cr
- Δ value
- down ₹8.8 Cr
- Status
- Trimmed
- Weight
- 1.61%
- Δ weight
- down 0.17 pts
- Value
- ₹141 Cr
- Δ value
- down ₹13 Cr
- Status
- Trimmed
- Weight
- 1.23%
- Δ weight
- up 0.30 pts
- Value
- ₹108 Cr
- Δ value
- up ₹27.2 Cr
- Status
- Added
- Weight
- 1.22%
- Δ weight
- down 0.06 pts
- Value
- ₹107 Cr
- Δ value
- down ₹3.7 Cr
- Status
- Trimmed
- Weight
- 1.15%
- Δ weight
- up 0.02 pts
- Value
- ₹101 Cr
- Δ value
- up ₹3.3 Cr
- Status
- Added
- Weight
- 0.97%
- Δ weight
- down 0.12 pts
- Value
- ₹85.2 Cr
- Δ value
- down ₹9.5 Cr
- Status
- Trimmed
- Weight
- 0.75%
- Δ weight
- down 0.02 pts
- Value
- ₹65.8 Cr
- Δ value
- down ₹53 L
- Status
- Trimmed
- Weight
- 0.58%
- Δ weight
- up 0.09 pts
- Value
- ₹51.1 Cr
- Δ value
- up ₹8.9 Cr
- Status
- Added
- Weight
- 0.50%
- Δ weight
- up 0.01 pts
- Value
- ₹44.1 Cr
- Δ value
- up ₹1.8 Cr
- Status
- Added
- Weight
- 0.43%
- Δ weight
- up 0.03 pts
- Value
- ₹37.7 Cr
- Δ value
- up ₹2.9 Cr
- Status
- Added
- Weight
- 0.29%
- Δ weight
- up 0.02 pts
- Value
- ₹25.7 Cr
- Δ value
- up ₹2.3 Cr
- Status
- Added
- Weight
- 0.26%
- Δ weight
- down 0.03 pts
- Value
- ₹22.7 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
What changed, Aug 2024 to Sep 2024
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹68.9 Cr (+0.60% pts)
- Divi's Laboratories Limitedup ₹47.2 Cr (+0.43% pts)
- Sanofi Consumer Healthcare India Limitedup ₹27.2 Cr (+0.30% pts)
- Apollo Hospitals Enterprise Limitedup ₹17.6 Cr (+0.13% pts)
- Vijaya Diagnostic Centre Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Aug 2024, the weight rose most in Healthcare Services (+0.1 pts).
- Healthcare Services17.7% → 17.8%+0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Sep 2021 | Sep 2023 | Mar 2024 | Jun 2024 | Aug 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 76.1% | 78.0% | 79.4% | 78.7% | 79.0% | 79.0% |
| Healthcare Services | 21.8% | 16.3% | 16.7% | 17.6% | 17.7% | 17.8% |
| Retailing | — | 4.3% | 3.1% | 2.9% | 2.5% | 2.4% |
| Pharmaceuticals | 2.1% | 1.1% | 0.9% | 0.8% | 0.8% | 0.8% |
Allocation in Sep 2024change vs Aug 2024
- Pharmaceuticals & Biotechnology (22)79.0%▼ 0.1 pts
- Healthcare Services (9)17.8%▲ 0.1 pts
- Retailing (1)2.4%
- Pharmaceuticals (1)
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Sep 2024
3.7%
▲ 1.1 pts vs Aug 2024
- Cash alone
- 3.8%
- cash and net receivables
- A year earlier
- 3.9%
- Sep 2023 · now ▼ 0.2 pts
- Last 12 months
- 0.5% – 3.9%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.